Sunday, 13 May 2012

Leukaemia Cured in 3 Months With Salvestrols

Chronic Lymphocytic Leukaemia Responds to Salvestrols

My mother introduced me to her friend, an 81-year old lady who had been diagnosed with Chronic Lymphocytic Leukaemia. When I met her she had a large 3 cm tumour in the lymph glands of her neck and was finding eating difficult. She was also having trouble sleeping due to swelling and tenderness of the lymph glands under the arms and in the groin. She did not look at all well and had an ashen complexion. I explained to her how salvestrols work naturally by triggering the destruction of the cancer cells from within. She commenced taking one Salvestrol Platinum (2000 point) capsule each day for a period of 3 months. During this time there was a marked improvement in her condition. The tumour in her neck started shrinking rapidly and reduced to half its size within 1 month. The swelling in the lymph glands also quickly subsided and she was able to start sleeping properly again. After 2 months the tumour in her neck had gone. After 3 months she returned to her doctor who declared that there were no signs of cancer in her body. She has continued taking 1 Salvestrol Shield daily both as a preventative measure against the cancer returning, and because she says the salvestrols make her feel good. I met her recently, 6 months after she was diagnosed, and she looked very healthy with a rosey complexion. The fast response rate here is impressive and this occurred at a dose of only one capsule of Salvestrol Platinum (2000 points) daily.


  1. Hi jez. Can you please tell me how Salvestrols can be used to help a wee three year old with leukaemia. There is a little guy who has been to England and back for a drug trial that failed ( from new Zealand) and his story has pulled the heart strings of our town. His name is chase. Regards Debbie

  2. Hi Debbie, thanks for telling me about Chase. The salvestrols should work at a low dose of 1 salvestrol platinum capsule daily. In the example given the lady with Chronic Lymphocytic Leukaemia responded to this dose.